Recent Developments
View PDF FDA APPROVES DERMIRA’S QBREXZA CLOTH TO TREAT PRIMARY AXILLARY HYPERHIDROSIS The FDA has approved Qbrexza (glycopyrronium) cloth, an anticholinergic indicated for the topical treatment of primary axillary hyperhidrosis in adult and pediatric patients nine years of age and older. Qbrexza is applied directly to the skin and is designed to block sweat […]